PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
20-Dec-2023 Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH) M1 Kliniken AG
20-Dec-2023 DOUGLAS with record sales and earnings Douglas GmbH
20-Dec-2023 Xlife Sciences AG paves the way for the next successful out-licensing and announces cooperation with Quant Biomarkers AG for the development of advanced biomarkers for kidney diseases Xlife Sciences AG
19-Dec-2023 Almirall to participate in the 42nd Annual J.P. Morgan Healthcare Conference Almirall S.A. (BME: ALM),
19-Dec-2023 Otsuka and Ionis enter into licensing agreement covering Europe for hereditary angioedema Otsuka Pharmaceutical Europe Ltd
19-Dec-2023 Biosynth to Offer Complex Chemistry Solutions at Greater Scales Following Acquisition of VIO Chemicals Biosynth
19-Dec-2023 New hot-flush treatment VEOZA▼™ (fezolinetant): first-in-class non-hormonal medicine for moderate to severe vasomotor symptoms associated with menopause licensed in Great Britain Astellas Pharma Inc
19-Dec-2023 Shionogi announces agreement with SOBI on Fetcroja®▼ (cefiderocol) to expand access for patients with infections due to aerobic Gram-negative organisms in adults with limited treatment options. Shionogi B.V.
19-Dec-2023 Santhera’s AGAMREE (Vamorolone) Approved in the European Union for the Treatment of Duchenne Muscular Dystrophy Santhera Pharmaceuticals
19-Dec-2023 Recipharm Harmonises its Global Quality Operations with Veeva Vault Quality Veeva Systems
19-Dec-2023 Shorla Oncology & EVERSANA Announce U.S. Commercial Launch of FDA-Approved JYLAMVO, the First and Only Oral Methotrexate Solution Approved in the U.S. for Adults Shorla Oncology
19-Dec-2023 CureVac Announces Decision of German Federal Patent Court in Broad Patent Litigation with BioNTech SE CureVac
19-Dec-2023 Mainz Biomed and Bantleon Partner to Elevate Corporate Health with Second Phase of CRC Screening Program for Employees Mainz BioMed N.V.
19-Dec-2023 SCHOTT Pharma delivers right after IPO with strong profitable growth for the full year, at the upper end of its guidance SCHOTT Pharma AG & Co. KGaA
19-Dec-2023 Evotec receives US$ 2.5 m grant to leverage human iPSC-derived teratogenicity platform for global health programmes Evotec SE
18-Dec-2023 Marinomed Biotech AG evaluates strategic options for Carragelose portfolio Marinomed Biotech AG
18-Dec-2023 Marinomed Biotech AG evaluates strategic options for Carragelose portfolio Marinomed Biotech AG
18-Dec-2023 Revolutionary AI Algorithm «Prostate.Carcinoma.ai» Achieves EU MDR Class IIa Registration Xlife Sciences AG
15-Dec-2023 2024 Voluntary Scheme agreement published ABPI
15-Dec-2023 Original-Research: HAEMATO AG (von GBC AG) HAEMATO AG